Breakthrough stem cell therapy shows potential in the treatment of multiple sclerosis
Kyiv • UNN
A new stem cell treatment for multiple sclerosis has demonstrated safety and potential to prevent nerve damage in a small, early-stage study, with cells injected directly into the patient's brain showing favorable long-term effects.
Doctors are cautiously optimistic about a new treatment for multiple sclerosis of multiple sclerosis. The method involves injecting stem cells into the brain of into the brains of patients. Clinical studies have shown that this treatment is safe and has the potential to prevent further damage to nerve tissue in multiple sclerosis. This is reported by The Guardian, according to UNN.
Details
Despite the fact that the study is relatively small and is only at an early stage, it allowed us to assess the tolerability of cell injections by patients directly into the brain. The results of observations of patients who agreed to undergo this therapy to undergo this therapy over the past year have shown that injections can have a have a long-term and favorable effect on health.
We don't know yet whether this is the beginning of a fantastic journey or not, but the results are very convincing and consistent
The publication clarifies that according to the WHO, more than 2 million people in the world people worldwide are struggling with multiple sclerosis. At the same time, most of the drugs are designed to treat the disease in the early stages. However, such treatment is characterized by relapses and remissions. WHO statistics show that two-thirds of of patients 30 years after diagnosis go into a secondary progressive stage, which causes disability.
In the case of multiple sclerosis, the body's immune system attacks the protective myelin sheaths surrounding the nerve fibers. This leads to damage to the entire nervous system and impaired transmission of electrical signals.
SEE ALSO: Anti-aging therapy: its methods, benefits, and the impact of stress on aging
In a new trial conducted on humans, researchers injected directly into the brains of patients with progressive multiple from 5 to 24 million neural stem cells directly into the brains of patients with progressive multiple sclerosis. It is assumed that stem cells reduce inflammation. Some patients experienced side effects during the experimental side effects such as tremors and steroid psychosis were observed in some patients during the experimental treatment. However, these symptoms quickly resolved after the start of appropriate therapy.
Supplement
Overall, the study showed that none of the subjects with progressive stage of multiple sclerosis did not worsen symptoms and did not disability. Despite the fact that most of them were already using wheelchairs wheelchairs before the trial began. Experts believe that if it were not for the treatment stem cell treatment, their patients' condition would have worsened.
Professor Paolo Muraro, a neuroimmunology expert from Imperial College London, who was not involved in the study, said that the results of this experiment set "a benchmark for the production and quality control of cellular drugs."
However, he said, additional challenges remain, one of which of which is the scaling up of the therapy and its availability for larger trials. And this is a long road, but certainly a worthy one."
